<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Effects of two doses of glucose and a caffeine-glucose combination on cognitive performance and mood during multi-tasking</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2014-07-28">28 July 2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Scholey</surname></persName>
							<email>andrew@scholeylab.com</email>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre for Human Psychopharmacology</orgName>
								<orgName type="institution">Swinburne University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><surname>Savage</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre for Human Psychopharmacology</orgName>
								<orgName type="institution">Swinburne University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barry</forename><forename type="middle">V</forename><surname>O'neill</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">GlaxoSmithKline</orgName>
								<address>
									<region>Middlesex</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lauren</forename><surname>Owen</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre for Human Psychopharmacology</orgName>
								<orgName type="institution">Swinburne University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Con</forename><surname>Stough</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre for Human Psychopharmacology</orgName>
								<orgName type="institution">Swinburne University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caroline</forename><surname>Priestley</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">GlaxoSmithKline</orgName>
								<address>
									<region>Middlesex</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Wetherell</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">Northumbria University</orgName>
								<address>
									<settlement>Newcastle-upon-Tyne</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="laboratory">Centre for Human Psychopharmacology</orgName>
								<orgName type="institution">Swinburne University</orgName>
								<address>
									<postCode>3122</postCode>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Effects of two doses of glucose and a caffeine-glucose combination on cognitive performance and mood during multi-tasking</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Human Psychopharmacology: Clinical and Experimental</title>
						<title level="j" type="abbrev">Hum. Psychopharmacol Clin Exp</title>
						<idno type="ISSN">0885-6222</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">29</biblScope>
							<biblScope unit="issue">5</biblScope>
							<biblScope unit="page" from="434" to="445"/>
							<date type="published" when="2014-07-28">28 July 2014</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1002/hup.2417</idno>
					<idno type="PMID">25196040</idno>
					<idno type="PMCID">PMC4265209</idno>
					<idno type="ark">ark:/67375/WNG-78MXLW5M-H</idno>
					<idno type="istexId">AED0DE7777C9DED7D6D05FB21B1A8D80A2EEC0D0</idno>
					<ptr type="open-access" target="http://europepmc.org/articles/pmc4265209?pdf=render" />
					<note type="submission">Received 18 December 2013 Accepted 12 May 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>Background This study assessed the effects of two doses of glucose and a caffeine-glucose combination on mood and performance of an ecologically valid, computerised multi-tasking platform. Materials and methods Following a double-blind, placebo-controlled, randomised, parallel-groups design, 150 healthy adults (mean age 34.78 years) consumed drinks containing placebo, 25 g glucose, 60 g glucose or 60 g glucose with 40 mg caffeine. They completed a multitasking framework at baseline and then 30 min following drink consumption with mood assessments immediately before and after the multitasking framework. Blood glucose and salivary caffeine were co-monitored. Results The caffeine-glucose group had significantly better total multi-tasking scores than the placebo or 60 g glucose groups and were significantly faster at mental arithmetic tasks than either glucose drink group. There were no significant treatment effects on mood. Caffeine and glucose levels confirmed compliance with overnight abstinence/fasting, respectively, and followed the predicted post-drink patterns. Conclusion These data suggest that co-administration of glucose and caffeine allows greater allocation of attentional resources than placebo or glucose alone. At present, we cannot rule out the possibility that the effects are due to caffeine alone Future studies should aim at disentangling caffeine and glucose effects.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Caffeine and glucose are two of the most widely consumed centrally active substances in the world. Caffeine (and to a lesser extent glucose) are used partly because of their potential cognition-enhancing properties. Although they are often co-consumed, including increasingly in the form of energy drinks, there is surprisingly little research examining the effects of the two substances in combination in the context of neurocognitive function.</p><p>The mood and cognitive effects of caffeine have been comprehensively reviewed elsewhere <ref type="bibr" target="#b6">(Glade, 2010;</ref><ref type="bibr" target="#b17">Rogers et al., 2011;</ref><ref type="bibr" target="#b28">Smith, 2002)</ref>. Typically, administration of caffeine in the range of 50 to 150 mg improves reaction times, psychomotor function, attention, vigilance and alertness-with the effects being particularly evident in fatigued individuals. Lower doses of caffeine have been less thoroughly researched, but doses as low as 12.5 mg, a level roughly equivalent to half a serving of cola, have been shown to be psychopharmacologically active <ref type="bibr" target="#b26">(Smit and Rogers, 2000)</ref>.</p><p>Glucose is the primary source of energy for the brain and, as such, is essential for central nervous system functioning. It has been extensively reported that cognitive performance can be enhanced following administration of drinks containing 25-50 g glucose. The effect is most apparent on tasks with a declarative memory component and/or those with heavier cognitive demands <ref type="bibr" target="#b1">(Benton et al., 1994;</ref><ref type="bibr" target="#b3">Donohoe and Benton, 1999;</ref><ref type="bibr" target="#b15">Riby, 2004;</ref><ref type="bibr" target="#b23">Scholey et al., 2009b;</ref><ref type="bibr" target="#b18">Scholey and Fowles, 2002;</ref><ref type="bibr" target="#b20">Scholey et al., 2001;</ref><ref type="bibr" target="#b32">Sünram-Lea et al., 2008)</ref>, including dual tasking <ref type="bibr" target="#b5">(Foster et al., 1998;</ref><ref type="bibr" target="#b23">Scholey et al., 2009b;</ref><ref type="bibr" target="#b29">Smith et al., 2011;</ref><ref type="bibr" target="#b31">Sünram-Lea et al., 2002;</ref><ref type="bibr" target="#b24">Scholey et al., 2013)</ref>.</p><p>Despite the abundance of studies investigating the behavioural effects of the two substances individually, there is surprisingly little research evaluating the mood and cognitive effects of caffeine and glucose both separately and together. This has been given further impetus from the fact that they are increasingly consumed concomitantly in so-called energy drinks.</p><p>One recent study investigating the combined and separate effects of 75 g glucose and 75 mg caffeine revealed beneficial effects to both sustained attention and learning from the combination <ref type="bibr" target="#b0">(Adan and Serra Grabulosa, 2010</ref>). These effects were not observed in either the caffeine-only or glucose-only condition. In a follow-up study that used the same doses and included a functional magnetic resonance imaging component, the same group found no differences in performance of an attentional task between glucose, caffeine and their combination <ref type="bibr" target="#b25">(Serra Grabulosa et al., 2010)</ref>. Functional imaging during task performance, however, revealed lower activation of parietal and prefrontal cortices in the caffeine-glucose condition. These findings can be interpreted as suggesting that the caffeine-glucose drink increased 'neural efficiency', such that less brain activation was required to maintain a level of cognitive performance.</p><p>The doses used in both the aforementioned studies were 75 g glucose and 75 mg caffeine. This caffeine level is consistent with, for example, coffee, which typically contains between 50 and 100 mg caffeine. Energy drinks can also contain caffeine in the range of 75 to 200 mg caffeine or more per serving. Some, however, have lower levels more typical of colas <ref type="bibr">(35-45 mg)</ref>.</p><p>Regarding the amount of glucose used in the Adan and Serra Grabulosa studies, 75 g is far higher than the levels found in sweetened coffee or tea. It is also higher than the 25-50 g used in studies into glucose effects on cognition <ref type="bibr" target="#b15">(Riby, 2004)</ref> and is relatively high compared with many caffeinated beverages such as energy drinks, which typically contain around half this amount.</p><p>Earlier studies have examined the cognitive effects of glucose and caffeine at levels more typical of everyday consumption. Compared with a glucose-andcaffeine-free control, drinks containing glucose/ caffeine at both 68 g/38 mg and 68 g/46 mg improved performance during sustained, cognitively demanding tasks . Other studies indicate an additive or even synergistic effect between caffeine and glucose on various domains of cognition. In separate studies, 37.5 g glucose, 75 mg caffeine drinks improved sustained attention, working memory <ref type="bibr" target="#b27">(Smit et al., 2004)</ref>, declarative memory and speed of attention <ref type="bibr" target="#b19">(Scholey and Kennedy, 2004)</ref> above levels of either substance alone.</p><p>The distribution of attentional resources over multiple tasks engages a number of mental processes that increase cognitive demand relative to a single task performance. Moreover, the ability to effectively and accurately multi-task has great utility in planning and decision making in everyday life. Interventions that have the capacity to improve these cognitive abilities are therefore of interest both scientifically and practically. The current study was therefore designed to assess the potential effects of glucose (two doses, 25 and 60 g) and a caffeine-glucose combination (60 g glucose, 40 mg caffeine) on cognitive performance and mood associated with cognitive multi-tasking. Specifically, it aimed to investigate effects on 'everyday' cognition using a multi-tasking framework (MTF)-comprising four tasks completed simultaneously-and on mood ratings taken before and after completion of the MTF.</p><p>Two main hypotheses were tested. The primary hypothesis was that, compared with placebo, caffeineglucose in combination would result in improved cognitive multi-tasking performance as measured by overall MTF scores. We have previously argued that glucose preferentially targets more mentally effortful cognitive processes. Glucose is particularly effective at increasing performance during effortful processing, including during dual attention tasks <ref type="bibr" target="#b23">(Scholey et al., 2009b;</ref><ref type="bibr" target="#b31">Sünram-Lea et al., 2002)</ref>. As dividing cognitive resources over several tasks involves relatively high mental effort, we hypothesised that the two doses of glucose alone would also improve performance. The secondary hypotheses were that, compared with placebo and/or glucose alone, the caffeine-glucose combination would improve task performance on individual tasks from the MTF and improve subjective feelings of mood, stress and fatigue during extended cognitive multi-tasking.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design</head><p>The investigation was a single-centre, randomised, double-blind, placebo-controlled, parallel-groups study conducted at the Centre for Human Psychopharmacology, Swinburne University, Australia. The study was approved by the Swinburne University Human Research Ethics Committee (ref SUHREC #2010/ 299) and conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent. The trial was registered on the Australian New Zealand Clinical Trials Registry (ANZCTR) as ACTRN12613000247774.</p><p>The study assessed the effects of two doses of glucose alone (25 and 60 g) and one dose of a (40 mg, 60 g) caffeine-glucose combination on cognitive performance, fatigue, stress and mood associated with extended multi-tasking.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p>One hundred and sixty healthy adults (male and female) aged between 18 and 55 years were recruited for the study. Participants were recruited from the investigators' existing database and via local media advertising. All participants were healthy, non-smoking, regular caffeine consumers with no significant concurrent illnesses or a history of psychiatric disease.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood glucose measurement</head><p>Blood glucose levels were monitored using a MediSense Optium Xceed Blood Glucose Sensor and disposable MediSense Blood Glucose Electrodes (MediSense Britain Ltd, Birmingham, UK). The accuracy and consistency of MediSense blood glucose sensors have previously been established <ref type="bibr" target="#b12">(Matthews et al., 1987)</ref>. The reliability of the test has previously been confirmed. Blood samples were taken using Owen Mumford 'Unistik 2' single-use capillary blood sampling devices <ref type="bibr">(Owen Mumford Ltd, Oxford, UK)</ref>. Alcohol-soaked skin cleansing swabs (Briemarkap, Koo Wee Rup, Victoria, Australia) were used for pre-sampling sterilisation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Salivary caffeine measurement</head><p>Saliva samples were collected using salivettes. These consist of a small test tube fitted with an inner receptacle containing a sterile cotton wool bud. Participants were required to remove the cotton wool bud and place it in the mouth, chewing gently for approximately 2 min and then replacing it in the test tube. The test tube with the saliva-cotton wool was then centrifuged, and the sample frozen for analysis. Salivary caffeine was measured using a caffeine immunoassay as previously described <ref type="bibr" target="#b8">(Haskell et al., 2005)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multi-tasking framework</head><p>A computerised MTF was used. This platform offers relatively high ecological validity in terms of the cognitive demands required to complete several disparate tasks simultaneously in the work environment <ref type="bibr" target="#b33">(Wetherell and Carter, 2013)</ref>. The computerised MTF comprises four cognitive and psychomotor tasks that are undertaken simultaneously using a four-way split screen.</p><p>Responses to all of the tasks are made using the mouse and cursor. Completion of the battery for an extended period has been shown to induce stress-related physiological processes <ref type="bibr" target="#b34">(Wetherell and Sidgreaves, 2005)</ref> and to modulate subjective feelings of mood, including decreased alertness and increased mental fatigue and anxiety <ref type="bibr" target="#b22">Scholey et al., 2009a)</ref>. In terms of cognitive performance, the MTF has also been shown to be sensitive to a number of natural interventions, including food supplements and herbal extracts <ref type="bibr" target="#b11">(Kennedy et al., 2006;</ref>.</p><p>In this study, a 20-min version of the MTF was employed with the framework set at medium intensity (see <ref type="bibr">Scholey et al., 2009a, for details)</ref>. The individual MTF tasks used here were as follows (arranged clockwise from top left).</p><p>Mathematical processing task. A series of addition calculations are presented. Each calculation requires the participant to add two numbers together, entering the three-figure answer via an onscreen number pad. On completion of each calculation, the participant clicks the 'done' button, which cues the next calculation. The outcomes are the speed of performance (number of calculations completed in 20 min) and accuracy (% correct). The module also generates an overall score incorporating correct answers (+10 points) and incorrect answers (À10 points).</p><p>Stroop colour-word task. Words describing one of four colours ('RED', 'YELLOW', 'GREEN' and 'BLUE') are presented in different coloured fonts. The participant clicks on colour panels in order to identify the font colour (e.g. if the word 'GREEN' is presented in a blue font, the correct response would be to click on the blue panel). If the participant fails to respond within 20 s, the task times out and the stimulus is replaced. The outcomes are the speed of performance (number of responses within 20 min) and accuracy (% correct). The module also generates an overall score incorporating correct answers (+10 points), incorrect answers (À10 points) and timeouts (À10 points).</p><p>Memory search task. Four letters appear for the participants to remember. After 4 s, the letters disappear but can be viewed again by clicking on 'retrieve list' button. Every 10 s, a single target letter appears. Participants are instructed to indicate whether the target letter had appeared in the original list of four letters by clicking on the 'yes' or 'no' buttons. If the participant fails to respond within 15 s, the task times out and the stimulus is replaced. The outcomes are the speed of performance (number of responses within 20 min) and accuracy (% correct). The module also generates an overall score incorporating the number of responses (+10 points each), incorrect responses (À10 points) and timeouts (À10 points).</p><p>Target tracker. A red dot moves slowly outwards from the centre of target-shaped concentric circles hold (at a speed of approximately 3 s/cm). Participants must click on one of two 'reset' buttons before the dot reaches the outer circle in order to re-centre the dot. Each larger circle increases the score by two points, from two to a maximum of 10 points. The red dot will begin to flash when touching the outer circle if reset buttons are not pressed, losing 10 points per 0.5 s until a response is made. The outcomes are the speed of performance (number of responses within 20 min) and accuracy (% correct). The module also generates an overall score incorporating number of responses and timeouts.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pencil-and-paper measures</head><p>Bond-Lader visual analogue mood scales. The <ref type="bibr" target="#b2">Bond and Lader (1974)</ref> mood scales have been utilised in numerous pharmacological, psychopharmacological and medical trials. The measure comprises 16 × 100 mm visual analogue mood scales with the endpoints anchored by the following antonyms: alert-drowsy, calm-excited, strong-feeble, muzzy-clearheaded, well coordinatedclumsy, lethargic-energetic, contented-discontented, troubled-tranquil, mentally slow-quick witted, tenserelaxed, attentive-dreamy, incompetent-proficient, happy-sad, antagonistic-friendly, interested-bored and withdrawn-sociable. Participants were presented with a sheet of paper containing the scales and instructed to mark their current mood state on each line. These are combined as recommended by the authors to form three mood factors, 'alert', 'calm' and 'contented', with scores on each ranging from 0 to 100.</p><p>Stress and fatigue visual analogue mood scales. These single visual analogue scales aim to gauge subjective mood at the present moment. The items consist of single 100-mm lines labelled 'stress' and 'fatigue' with the endpoints labelled 'not at all' and 'extremely'.</p><p>State-Trait Anxiety Inventory-State portion. The State-Trait Anxiety Inventory (STAI; Spielberger et al., 1970) comprises two scales. The 'State' (STAI-S) subscale is a widely used instrument for measuring fluctuating levels of anxiety. Participants rate how much statements match their current state by marking a 4-point scale ranging from not at all to very much so. The subscale contains 20 statements (e.g. 'I am calm'). Scores range from 20 to 80, with higher scores indicating more anxiety.</p><p>The National Aeronautics and Space Administration Task Load Index perceived workload questionnaire. The National Aeronautics and Space Administration Task Load Index (NASA-TLX; <ref type="bibr" target="#b7">Hart and Staveland, 1988</ref>) assesses work load. Participants rate the perceived effort (from very low to very high) involved in performing the MTF along six dimensions. Three gauge the demand placed upon the respondent by the task (mental demand, physical demand and temporal demand), and three gauge elements of the interaction between participant and task (effort, frustration and perceived performance).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatments</head><p>On their study day, each participant received one of four treatments supplied in the form of a 330 ml orange-flavoured drink in unlabelled bottles in opaque sleeves. The drinks comprised (i) placebo, a commercial sugar-free fizzy orange drink; (ii) 25 g glucose, in the form of a fruit-flavoured, carbonated drink (iii) 60 g glucose, in a carbonated, fruit-flavoured drink and (iv) caffeineglucose, in the form of a commercially available, fruitflavoured, carbonated drink containing 40 mg caffeine and 60 g glucose. Note that the glucose was in the form of glucose syrup formulated to release 60 g of glucose when broken down.</p><p>Randomisation to treatment was achieved by allocating each individual to a condition as determined by a disinterested third party who played no other part in the study.</p><p>All products contained inactive commercially available food ingredients including sweeteners (sucralose/ acesulfame K), acidulant (malic acid), preservative (potassium sorbate) and flavourings. Each participant was allowed 5 min to consume one of the treatments during their testing visit. Treatment bottles were placed in identical sleeves before consumption to maintain the double blind by preventing sighting of colour/texture differences between the treatments by researcher or participant.</p><p>Products were manufactured and supplied by GSK Nutritional Healthcare R&amp;D (Brentford, UK) who monitored and approved chemical, sensorial and microbiological stability of the products used on study initiation and for the duration of the study. The levels of caffeine were determined by analysis, and confirmed before the start of the study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Procedure</head><p>Participants visited the laboratory on two occasions. The first was an initial practice session, where they signed a participant informed consent form indicating comprehension and compliance with study processes and were allocated a study identification number. Morphometric and demographic data were recorded as well as details of any relevant medical history and concomitant medications. The practice session also included measures of personality and emotional intelligence (paper questionnaires) for purposes unrelated to the current study. These included the Trait portion of the Spielberger State-Trait Anxiety scale, the Profile of Mood States, the Swinburne University Emotional Intelligence Test and the Neuroticism-Extroversion-Openness Inventory Five Factor Inventory. Participants were familiarised with the mood questionnaires including the Bond-Lader, STAI-S, visual analogue scales and NASA-TLX and practiced completing the computer-based cognitive MTF. This served to familiarise subjects with task requirements and to attenuate any practice effects.</p><p>The subsequent visit comprised the study days that took place at least 24 h after the practice visit [mean 6.51 days, standard deviation (SD) 4.52]. Participants were instructed to fast for 12 h prior to study days and to abstain from drinking alcohol and caffeinated drinks for 24 and 12 h, respectively. The study day testing session lasted for 1.5 h. Upon arrival, participants provided blood and saliva for baseline fasted glucose and caffeine measurement, respectively. Following this, baseline mood, stress and fatigue measures were completed immediately before and after the computer-based MTF. The treatment drink was then administered to the participant who was allowed 5 min to consume the product. Exactly 30 min later (to allow for product absorption), a second blood glucose measure was taken. Participants again completed mood, fatigue and stress questionnaires immediately before and after completion of the MTF. After this session (60 min post-dose), final blood glucose measurement and salivary samples were provided. Participants were thanked and fully debriefed, and they were asked to indicate which condition they believed they had been in and then given the opportunity to ask questions of the experimenter before leaving the laboratory.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>STATISTICS</head><p>Sample size calculation. Sample size was determined on the basis of the data from . Mean change-from-baseline rapid visual information processing accuracy scores were averaged across the 30-, 40-and 50-min post-treatment measures for the 40 g caffeine plus 68 g glucose and the placebo conditions, respectively. The resulting effect size (Cohen's d) of 0.372 was used to calculate the sample size for a four-condition analysis of variance (ANOVA) using G*POWER v3.12 <ref type="bibr" target="#b4">(Faul et al., 2007)</ref>. This generated an N of 132 to detect a significant difference at an α level of 0.05 with 95% power. Given the exploratory nature of this study, and the possibility of attrition, the N was increased to 40/cell in order to optimise the chances of capturing treatment-related effects.</p><p>Data treatment and analysis. Data were analysed using the statistical software SPSS v20 for Windows unless otherwise stated.</p><p>Demographic and morphometric data were analysed using one-way ANOVA comparing treatments with pairwise comparisons where appropriate to ensure that the groups were matched. Blood glucose levels were analysed using a 2-way ANOVA examining effects of Treatment × Time (baseline, pre-testing, post-testing) with the latter as a within-subjects factor. Salivary caffeine was analysed using a 2-way ANOVA examining effects of Treatment × Time (pre-testing, post-testing) with the latter as a within-subjects factor.</p><p>The primary outcome was the overall multi-tasking score. Secondary outcomes included scores on the individual tasks. Multi-tasking performance (overall score and individual task scores) were analysed as follows. Each score was computed as change from baseline, group outliers were removed from resulting scores and data were then analysed by one-way ANOVA comparing treatments. Group differences were explored by all pairwise comparisons (least significant difference statistic).</p><p>Mood and stress reactivity (i.e. the changes in alertness, calmness, contentedness, state anxiety, stress and fatigue) were computed (post-stressor minus prestressor or Δ). The resulting scores were examined as change from baseline Δ and were analysed by oneway ANOVA in the same way as the performance scores. Changes in aspects of perceived effort as measured using the NASA-TLX were analysed by one-way ANOVA examining effects of treatment (drink). Planned pairwise comparisons (least significant difference) were conducted to establish differences between active treatments and placebo and between different active drinks.</p><p>Treatment guessing data were analysed by chi-square comparing the distribution of treatment guesses to chance within each condition using GRAPHPAD software (GraphPad Software, La Jolla, CA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participant characteristics</head><p>Of 160 participants enrolled into the study, there were 150 suitable datasets for analysis. The flow of participants through the study is presented in <ref type="figure" target="#fig_0">Figure 1</ref>.</p><p>Participants were non-smokers and regular caffeine consumers (at least one caffeinated beverage per day). Further demographic variables are presented in <ref type="table" target="#tab_0">Table 1</ref>, and there were no group differences in any demographic or morphometric measure.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood glucose</head><p>There was a significant time × condition interaction for blood glucose levels [F(6, 292) = 20.68, p &lt; 0.001]. Blood glucose levels did not differ at baseline [F(3, 146) = 0.91, p = 0.438]. There were significant group differences at both at the 30-min (pre-task) [F(3, 146) = 25.48, p &lt; 0.001] and 60-min (post-task) [F(3, 146) = 27.21, p &lt; 0.001] time points. Pairwise comparisons revealed that all measures were significantly higher than placebo at both post-baseline time points (p &lt; 0.005) and that the 25 g drink was associated with lower blood glucose levels than the caffeineglucose drink at the pre-task measure (p = 0.038) and both the 60 g drink and the caffeine-glucose drink at the post-test measure (p &lt; 0.005 in both cases). These data are plotted in <ref type="figure" target="#fig_1">Figure 2</ref> (upper panel).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Salivary caffeine</head><p>A threshold of 2000 ng/ml salivary caffeine was used as a cut-off for compliance to overnight caffeine withdrawal <ref type="bibr" target="#b16">(Rogers et al., 2005)</ref>. Compliance was high with no exclusions owing to supra-threshold salivary caffeine. There was, however, a high variability in baseline caffeine levels ranging from sub-detection levels to 1942 ng/ml.</p><p>There was a significant Treatment × Time interaction for salivary caffeine levels [F(3, 136) = 23.38, p &lt; 0.001]. Salivary caffeine levels did not differ at baseline [F(3, 136) = 0.34, p = 0.798]. There were significant differences in the post-task samples [F(3, 136) = 7.76, p &lt; 0.001] compared with those in the caffeine-glucose drink condition having significantly higher salivary caffeine levels than those in the placebo, 25 g glucose and 60 g glucose conditions (p &lt; 0.005). These data are plotted in <ref type="figure" target="#fig_1">Figure 2</ref> (lower panel).  Prior to analysing treatment effects, each outcome measure was subject to a one-way ANOVA comparing pre-treatment baseline scores in each treatment group (presented in <ref type="table" target="#tab_1">Table 2</ref>). There were no significant differences.</p><p>Regarding post-treatment effects, there was a significant main effect of treatment on the primary outcome variable, namely the overall multi-tasking score <ref type="bibr">[F(3, 146)</ref> = 3.56, p = 0.015]. Pairwise comparisons revealed a significant difference between placebo and the caffeine-glucose drink (p = 0.005), and between the 60 g glucose and the glucose + caffeine drinks (p = 0.006)-see <ref type="figure" target="#fig_2">Figure 3</ref>. There was a significant main effect of treatment on speed of performing the mathematical reasoning task [F(3, 145) = 4.14, p = 0.008]. The glucose + caffeine group performed significantly faster than the 25 g glucose group (p = 0.034) and the 60 g glucose group (p = 0.001). There was a trend for a treatment effect for speed of responding on the Stroop task [F(3, 143) = 2.62, p = 0.054]. The caffeine-glucose drink was associated with faster responses than the placebo and the 60 g glucose drink [p = 0.027 and p = 0.011, respectively].</p><p>There were no significant treatment effects on mood measures or perceived effort as gauged using the NASA-TLX. Mean scores for the mood measures and the NASA-TLX are presented in <ref type="table" target="#tab_2">Tables 3 and 4</ref>, respectively.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment guessing</head><p>Overall, there was a significant bias towards guessing the glucose conditions [χ 2 (3) = 17.093, p = 0.0007] with 38.67% and 25.33% guessing that they had received 25 and 60 g glucose, respectively, compared with 18% each guessing they had received the placebo and caffeine-glucose drinks. Within each condition, however, the distribution of guesses did not differ significantly for the placebo [χ 2 (3) = 0.407, ns], 25 g glucose [χ 2 (3) = 0.897, ns], 60 g glucose [χ 2 (3) = 3.684, ns] or caffeine-glucose [χ 2 (3) = 5.444, ns] <ref type="table">(Table 5)</ref>.</p><p>There were no adverse events.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>Supporting our hypothesis, there was a significant treatment effect on multi-tasking performance with those in the caffeine-glucose drink outperforming the placebo condition. Multi-tasking performance was also significantly better in the caffeine-glucose condition than in the 60 g glucose drink condition. These data are consistent with the hypothesis that a caffeineglucose drink can increase the amount of attentional resources, which can be allocated to task performance. This is in broad agreement with the results of a functional magnetic resonance imaging study showing lower levels of neural activation following a caffeine-glucose combination (albeit at different levels) than placebo or caffeine or glucose alone <ref type="bibr" target="#b25">(Serra Grabulosa et al., 2010)</ref>. Regarding the mechanisms underlying superior multi-tasking, we can be confident that the double blind was effective and that expectations as to conditions did not influence results. Treatment guessing  did not differ significantly by condition. We cannot, however, rule out the possibility that those in the caffeine-glucose condition were able to change their strategy to optimise their score. However, this seems unlikely as the most effective strategy to increase overall score is to focus on the working memory task, and there was no evidence that this was the case. There were significant improvements to the speed of performing mental arithmetic associated with the caffeine-glucose drink. Those in the combination drink were faster than either glucose drink alone, again suggesting that caffeine conferred a benefit to performance. Mathematical processing requires manipulation of information held in consciousness and, like multi-tasking, draws heavily on working memory and  executive processes. Taken together, these findings suggest that the caffeine-glucose combination can improve executive functioning through the allocation of more attentional resources to multi-task performance. There was also some evidence of improvements to the speed of responding on the Stroop module. The Stroop task is a classic measure of selective attention and response inhibition. Again, effective performance relies on executive responses-in this case, inhibiting the response to the word meaning in favour of its perceptual properties. Counter to our hypotheses, there were no behavioural effects of either dose of glucose alone. Those in the 25 g glucose condition had numerically better performance (although this did not approach statistical significance), whereas performance in the 60 g condition was similar to that in placebo and significantly worse than that in the caffeine-glucose drink. These performance differences between the two glucose-only conditions support the notion of an inverted U doseresponse curve for glucose on some aspects of cognition <ref type="bibr" target="#b15">(Riby, 2004)</ref>. With regard to specific outcomes, in previous studies examining the effects of glucose on sequentially performed tasks, 25 g glucose has improved working memory (serial subtraction) performance <ref type="bibr" target="#b20">(Scholey et al., 2001</ref>). On the other hand, performance of a task very similar to the working memory module in the current study was unaffected by 37.5 g glucose, either alone or in combination with glucose <ref type="bibr" target="#b19">(Scholey and Kennedy, 2004)</ref>. Owen et al. (2012) specifically compared the mood and cognitive effects of 25 and 60 g glucose drinks. Her data reveal a complex pattern of effects, with the two doses interacting differentially with task type and fast duration. The 25 g drink was associated with better serial sevens performance following a 2-h fast only, and faster choice reaction times following an overnight fast only. The 60 g dose speeded word recognition and improved serial threes performance following an overnight (but not 2 h) fast. None of the affected tasks were a direct analogue of those in the current study. Nevertheless, we have previously argued that tasks that require higher levels of mental effort for effective execution are more susceptible to the glucose enhancement effect. It might be assumed that multi-tasking would fall into this category, and indeed the mood changes associated performing the MTF support this contention. On the other hand, previous studies that have found effects of glucose (usually 25 g) during dual tasking have included more individual task such as effortful psychomotor tracking <ref type="bibr" target="#b23">(Scholey et al., 2009b)</ref> or repeated, alternating hand movements <ref type="bibr" target="#b31">(Sünram-Lea et al., 2002)</ref>. The effect may be because such tasks are more effortful than the MTF used in the current study, for example, co-performing hand movements can reduce memory performance to near chance levels <ref type="bibr" target="#b24">(Scholey et al., 2013;</ref><ref type="bibr" target="#b21">Scholey et al., 2006)</ref>. Alternatively, previous dual tasking studies have typically included a declarative memory component, which may be more susceptible to the glucoserelated enhancement. These positive effects seen here may be due to the additive/synergistic effects of glucose and caffeine in combination, supporting previous behavioural studies showing that the effects of caffeine and glucose together were significantly better than those of either substance alone <ref type="bibr" target="#b19">(Scholey and Kennedy, 2004)</ref>. Alternatively, at present, we cannot rule out the possibility that they may be attributable to caffeine contained within this treatment only. Future studies should compare the effects of caffeine alone with the other treatments used in the current study.</p><p>There were no mood changes associated with any drink. This is consistent with much of the previous literature regarding glucose. However, caffeine is often associated with alerting effects, although these are most easily detected in individuals who are in a deprivation state owing to (e.g.) fatigue and are most readily found with higher caffeine doses. In any case, these findings suggest that the significant improvement in multi-tasking performance following the caffeineglucose drink reflects direct effects on performance rather than a secondary effect of improved arousal/ alertness.</p><p>It is worth noting that the mean body mass index of the participants is towards the high end of the normal range (mean body mass index = 24.36, SD 4.47). We have previously reported that body composition differentially influences glucose absorption and possibly cognitive responses to glucose <ref type="bibr" target="#b14">(Owen et al., 2013)</ref>. Further work might usefully be directed to discerning the effect of body composition on cognitive responses to various nutritional interventions.</p><p>In summary, a drink containing 40 mg caffeine/60 g glucose improved performance of an ecologically valid task of multi-tasking. As the same drink improved aspects of executive functioning and attention, it is possible that increased allocation of attentional resources underlie this effect. Further work should be aimed at delineating the underlying mechanisms of these effects, including the use of functional brain imaging. It would be of great interest to examine different levels of glucose in combination with caffeine in order to determine the threshold levels of the two substances for positive effects on multi-tasking. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Flow of participants through the study, including numbers screened, entered into the study, lost to data capture errors and analysed</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Mean ± standard error of mean blood glucose levels (top) and salivary caffeine levels (bottom). For blood glucose a, significantly different to all other drink conditions; b, significantly different from caffeine-glucose; c, significantly different from 60 g glucose and caffeineglucose at same time point. For salivary caffeine levels *** p &lt; 0.005 at same time point</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Effects of treatment on multi-tasking performance. Bars show mean change from baseline scores ± standard error of mean. ** p &lt; 0.01</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc>OF INTEREST B. V. O. N. and C. P. are employees of GlaxoSmithKline. A. S., L. O. and C. S. have received research funding, consultancy and/or speakers fees from industry sources. The other authors declare no conflict of interest.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Demographic and morphometric characteristics of participants included in analysis</figDesc><table><row><cell></cell><cell>All</cell><cell>Placebo</cell><cell>25 g glucose</cell><cell>60 g glucose</cell><cell>Caffeine-glucose</cell></row><row><cell>N</cell><cell>150</cell><cell>37</cell><cell>38</cell><cell>39</cell><cell>36</cell></row><row><cell>M/F</cell><cell>58/92</cell><cell>12/25</cell><cell>17/21</cell><cell>14/25</cell><cell>15/21</cell></row><row><cell>Age</cell><cell>34.78 (10.63)</cell><cell>30.51 (10.00)</cell><cell>31.85 (11.02)</cell><cell>31.44 (10.32)</cell><cell>34.78 (11.09)</cell></row><row><cell>BMI</cell><cell>24.36 (4.45)</cell><cell>24.70 (4.05)</cell><cell>24.10 (5.22)</cell><cell>23.97 (3.65)</cell><cell>24.72 (4.86)</cell></row><row><cell>Years education</cell><cell>17.24 (3.02)</cell><cell>17.00 (2.56)</cell><cell>17.44 (3.44)</cell><cell>16.95 (2.71)</cell><cell>17.58 (3.33)</cell></row></table><note>Overall Ns and numbers of male/female (M/F) adults are shown along with mean (with standard deviation) age, body mass index (BMI), and years of education.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>Summary statistics showing treatment effects (mean and SD) on multi-tasking measures</figDesc><table><row><cell>Baseline</cell><cell></cell><cell cols="2">Post-treatment</cell><cell cols="2">Change from baseline</cell></row><row><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc>Summary statistics showing treatment effects (mean and SD) on mood measures</figDesc><table><row><cell></cell><cell></cell><cell cols="2">Baseline</cell><cell cols="2">Baseline</cell><cell cols="2">Baseline</cell><cell cols="2">Treatment</cell><cell cols="2">Treatment</cell><cell cols="2">Treatment</cell><cell>Change</cell></row><row><cell></cell><cell></cell><cell cols="2">pre-MTF</cell><cell cols="2">post-MTF</cell><cell cols="2">change</cell><cell cols="2">pre-MTF</cell><cell cols="2">post-MTF</cell><cell cols="2">change</cell><cell>pre-MTF</cell><cell>change Δ</cell></row><row><cell></cell><cell></cell><cell cols="4">Mean SD Mean SD</cell><cell>Mean</cell><cell cols="5">SD Mean SD Mean SD</cell><cell>Mean</cell><cell cols="2">SD Mean SD Mean SD</cell></row><row><cell>Alert</cell><cell>Placebo</cell><cell cols="2">57 20</cell><cell cols="2">59 17</cell><cell>2</cell><cell>15</cell><cell cols="2">66 15</cell><cell cols="2">65 18</cell><cell>À1</cell><cell>16</cell><cell>8</cell><cell>19</cell><cell>À2</cell><cell>20</cell></row><row><cell></cell><cell>25 g glucose</cell><cell cols="2">60 17</cell><cell cols="2">61 18</cell><cell>1</cell><cell>11</cell><cell cols="2">67 14</cell><cell cols="2">66 17</cell><cell>À1</cell><cell>10</cell><cell>7</cell><cell>13</cell><cell>À2</cell><cell>1</cell></row><row><cell></cell><cell>60 g glucose</cell><cell cols="2">56 20</cell><cell cols="2">53 19</cell><cell>À3</cell><cell>18</cell><cell cols="2">60 17</cell><cell cols="2">59 20</cell><cell>À1</cell><cell>16</cell><cell>4</cell><cell>17</cell><cell>2</cell><cell>20</cell></row><row><cell></cell><cell cols="3">Caffeine-glucose 63 18</cell><cell cols="2">60 19</cell><cell>À3</cell><cell>16</cell><cell cols="2">71 14</cell><cell cols="2">66 16</cell><cell>À5</cell><cell>15</cell><cell>9</cell><cell>14</cell><cell>À2</cell><cell>18</cell></row><row><cell>Calm</cell><cell>Placebo</cell><cell cols="2">67 16</cell><cell cols="2">58 20</cell><cell>À9</cell><cell>18</cell><cell cols="2">58 65</cell><cell cols="2">54 19</cell><cell>À4</cell><cell>16</cell><cell>À9</cell><cell>20</cell><cell>6</cell><cell>22</cell></row><row><cell></cell><cell>25 g glucose</cell><cell cols="2">69 13</cell><cell cols="2">58 18</cell><cell>À10</cell><cell>17</cell><cell cols="2">65 17</cell><cell cols="2">55 22</cell><cell>À10</cell><cell>15</cell><cell>À4</cell><cell>13</cell><cell>1</cell><cell>13</cell></row><row><cell></cell><cell>60 g glucose</cell><cell cols="2">64 17</cell><cell cols="2">57 16</cell><cell>À8</cell><cell>16</cell><cell cols="2">60 16</cell><cell cols="2">55 16</cell><cell>À5</cell><cell>13</cell><cell>À4</cell><cell>18</cell><cell>3</cell><cell>17</cell></row><row><cell></cell><cell cols="3">Caffeine-glucose 70 15</cell><cell cols="2">59 18</cell><cell>À12</cell><cell>13</cell><cell cols="2">61 20</cell><cell cols="2">59 21</cell><cell>À2</cell><cell>20</cell><cell>À9</cell><cell>16</cell><cell>10</cell><cell>17</cell></row><row><cell>Content</cell><cell>Placebo</cell><cell cols="2">70 16</cell><cell cols="2">68 16</cell><cell>À2</cell><cell>12</cell><cell cols="2">72 14</cell><cell cols="2">73 14</cell><cell>1</cell><cell>11</cell><cell>2</cell><cell>13</cell><cell>4</cell><cell>15</cell></row><row><cell></cell><cell>25 g glucose</cell><cell cols="2">70 15</cell><cell cols="2">69 15</cell><cell>À1</cell><cell>10</cell><cell cols="2">73 13</cell><cell cols="2">72 15</cell><cell>À2</cell><cell>8</cell><cell>3</cell><cell>9</cell><cell>À1</cell><cell>10</cell></row><row><cell></cell><cell>60 g glucose</cell><cell cols="2">67 12</cell><cell cols="2">62 12</cell><cell>À5</cell><cell>13</cell><cell cols="2">69 11</cell><cell cols="2">66 13</cell><cell>À3</cell><cell>10</cell><cell>2</cell><cell>12</cell><cell>2</cell><cell>11</cell></row><row><cell></cell><cell cols="3">Caffeine-glucose 71 20</cell><cell cols="2">67 16</cell><cell>À4</cell><cell>15</cell><cell cols="2">72 13</cell><cell cols="2">71 12</cell><cell>À2</cell><cell>9</cell><cell>À1</cell><cell>10</cell><cell>3</cell><cell>19</cell></row><row><cell>Fatigue</cell><cell>Placebo</cell><cell>46</cell><cell cols="2">2.65 54</cell><cell>2.06</cell><cell cols="3">0.72 2.22 37</cell><cell cols="2">2.10 49</cell><cell>2.38</cell><cell cols="3">1.21 2.34 À0.92 2.34</cell><cell>0.59 2.92</cell></row><row><cell></cell><cell>25 g glucose</cell><cell>41</cell><cell cols="2">2.29 52</cell><cell>2.09</cell><cell cols="3">1.14 1.98 36</cell><cell cols="2">1.85 50</cell><cell>2.28</cell><cell cols="3">1.42 1.99 À0.47 1.48</cell><cell>0.33 2.18</cell></row><row><cell></cell><cell>60 g glucose</cell><cell>40</cell><cell cols="2">2.75 51</cell><cell>2.56</cell><cell cols="3">1.09 2.16 35</cell><cell cols="2">2.33 49</cell><cell>2.42</cell><cell cols="3">1.45 2.39 À0.57 2.88</cell><cell>0.42 3.13</cell></row><row><cell></cell><cell cols="2">Caffeine-glucose 39</cell><cell cols="2">2.69 53</cell><cell>2.47</cell><cell cols="3">1.39 2.23 29</cell><cell cols="2">1.83 44</cell><cell>2.48</cell><cell cols="3">1.55 2.51 À0.96 2.46 À0.18 1.97</cell></row><row><cell>Stress</cell><cell>Placebo</cell><cell>28</cell><cell cols="2">2.17 39</cell><cell>2.38</cell><cell cols="3">1.23 2.28 28</cell><cell cols="2">1.77 40</cell><cell>2.57</cell><cell cols="2">1.24 2.21</cell><cell>0.16 1.58</cell><cell>0.07 2.06</cell></row><row><cell></cell><cell>25 g glucose</cell><cell>26</cell><cell cols="2">1.98 39</cell><cell>1.99</cell><cell cols="3">1.31 2.02 29</cell><cell cols="2">1.94 41</cell><cell>2.24</cell><cell cols="2">1.22 2.02</cell><cell>0.24 1.94 À0.04 1.79</cell></row><row><cell></cell><cell>60 g glucose</cell><cell>23</cell><cell cols="2">1.98 38</cell><cell>2.12</cell><cell cols="3">1.50 1.71 25</cell><cell cols="2">1.89 35</cell><cell>2.27</cell><cell cols="2">0.97 1.99</cell><cell>0.23 1.91 À0.45 2.39</cell></row><row><cell></cell><cell cols="2">Caffeine-glucose 26</cell><cell cols="2">2.35 42</cell><cell>2.41</cell><cell cols="3">1.64 2.48 26</cell><cell cols="2">2.21 37</cell><cell>2.58</cell><cell cols="2">1.18 2.26</cell><cell>0.19 1.22 À0.84 2.39</cell></row><row><cell cols="2">State anxiety Placebo</cell><cell>45</cell><cell cols="2">5.05 44</cell><cell cols="4">5.17 À0.92 3.57 44</cell><cell cols="2">4.84 43</cell><cell cols="4">6.02 À0.05 4.8 À0.89 3.67</cell><cell>0.42 5.33</cell></row><row><cell></cell><cell>25 g glucose</cell><cell>45</cell><cell cols="2">5.60 43</cell><cell cols="4">5.06 À1.49 4.01 43</cell><cell cols="2">5.25 44</cell><cell>5.3</cell><cell>0.4</cell><cell cols="2">3.09 À1.65 3.67</cell><cell>1.89 5.13</cell></row><row><cell></cell><cell>60 g glucose</cell><cell>44</cell><cell cols="2">4.88 44</cell><cell cols="4">4.20 À0.27 4.07 43</cell><cell cols="2">5.24 43</cell><cell>5.89</cell><cell>0</cell><cell cols="2">4.82 À0.78 4.41</cell><cell>0.27 6.18</cell></row><row><cell></cell><cell cols="2">Caffeine-glucose 44</cell><cell cols="2">4.62 42</cell><cell cols="4">4.69 À2.84 3.85 44</cell><cell cols="2">5.46 42</cell><cell cols="4">6.41 À1.67 3.81 À1</cell><cell>2.85</cell><cell>1.16 4.15</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc>Summary statistics showing treatment effects (mean and SD) on measures derived from the NASA-TLX</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Baseline</cell><cell></cell><cell>Post-treatment</cell><cell></cell><cell>Change from baseline</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell></row><row><cell>Mental demand</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>61</cell><cell>21</cell><cell>60</cell><cell>24</cell><cell>À1</cell><cell>1 6</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>63</cell><cell>18</cell><cell>58</cell><cell>24</cell><cell>À4</cell><cell>1 9</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>53</cell><cell>23</cell><cell>53</cell><cell>25</cell><cell>À1</cell><cell>2 1</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>59</cell><cell>17</cell><cell>58</cell><cell>18</cell><cell>0</cell><cell>15</cell></row><row><cell>Physical demand</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>28</cell><cell>21</cell><cell>32</cell><cell>26</cell><cell>4</cell><cell>16</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>29</cell><cell>22</cell><cell>27</cell><cell>20</cell><cell>À2</cell><cell>1 3</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>29</cell><cell>25</cell><cell>33</cell><cell>26</cell><cell>5</cell><cell>12</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>24</cell><cell>18</cell><cell>31</cell><cell>22</cell><cell>8</cell><cell>18</cell></row><row><cell>Temporal demand</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>65</cell><cell>20</cell><cell>62</cell><cell>25</cell><cell>À3</cell><cell>2 2</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>63</cell><cell>19</cell><cell>61</cell><cell>24</cell><cell>À2</cell><cell>1 8</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>60</cell><cell>17</cell><cell>55</cell><cell>22</cell><cell>À5</cell><cell>1 9</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>60</cell><cell>18</cell><cell>55</cell><cell>21</cell><cell>À5</cell><cell>1 5</cell></row><row><cell>Performance</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>34</cell><cell>17</cell><cell>32</cell><cell>16</cell><cell>À3</cell><cell>1 9</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>41</cell><cell>17</cell><cell>37</cell><cell>21</cell><cell>À4</cell><cell>2 0</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>44</cell><cell>22</cell><cell>40</cell><cell>22</cell><cell>À4</cell><cell>2 0</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>35</cell><cell>20</cell><cell>33</cell><cell>22</cell><cell>À2</cell><cell>2 3</cell></row><row><cell>Effort</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>68</cell><cell>18</cell><cell>65</cell><cell>19</cell><cell>À2</cell><cell>1 1</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>66</cell><cell>17</cell><cell>63</cell><cell>24</cell><cell>À3</cell><cell>1 4</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>64</cell><cell>21</cell><cell>62</cell><cell>20</cell><cell>À2</cell><cell>1 8</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>62</cell><cell>18</cell><cell>56</cell><cell>21</cell><cell>À7</cell><cell>1 7</cell></row><row><cell>Frustration</cell><cell></cell><cell>Placebo</cell><cell></cell><cell>42</cell><cell>24</cell><cell>42</cell><cell>22</cell><cell>0</cell><cell>22</cell></row><row><cell></cell><cell></cell><cell>25 g glucose</cell><cell></cell><cell>36</cell><cell>23</cell><cell>36</cell><cell>24</cell><cell>0</cell><cell>16</cell></row><row><cell></cell><cell></cell><cell>60 g glucose</cell><cell></cell><cell>42</cell><cell>22</cell><cell>40</cell><cell>23</cell><cell>À2</cell><cell>2 2</cell></row><row><cell></cell><cell></cell><cell cols="2">Caffeine-glucose</cell><cell>36</cell><cell>26</cell><cell>37</cell><cell>23</cell><cell>1</cell><cell>20</cell></row><row><cell cols="6">Table 5. Number of participants guessing which treatment they had</cell><cell></cell><cell></cell></row><row><cell cols="2">received by condition</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2">Treatment guessed (N)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="5">Placebo 25 g glucose 60 g glucose Caffeine-glucose</cell><cell></cell><cell></cell></row><row><cell>Placebo</cell><cell>6</cell><cell>15</cell><cell>8</cell><cell>8</cell><cell></cell><cell></cell><cell></cell></row><row><cell>25 g glucose</cell><cell>6</cell><cell>17</cell><cell>10</cell><cell>5</cell><cell></cell><cell></cell><cell></cell></row><row><cell>60 g glucose</cell><cell>8</cell><cell>14</cell><cell>14</cell><cell>3</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Caffeine-glucose 7</cell><cell>12</cell><cell>6</cell><cell>11</cell><cell></cell><cell></cell><cell></cell></row><row><cell>p</cell><cell>0.938</cell><cell>0.826</cell><cell>0.298</cell><cell>0.142</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">p indicates probability of difference from chance values within each treat-</cell><cell></cell><cell></cell></row><row><cell>ment guessed.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">glucose, caffeine and multi-tasking © 2014 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley &amp; Sons, Ltd.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2014 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley &amp; Sons, Ltd. Hum. Psychopharmacol Clin Exp 2014; 29: 434-445. DOI: 10.1002/hup</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">glucose, caffeine and multi-tasking © 2014 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley &amp; Sons, Ltd. Hum. Psychopharmacol Clin Exp 2014; 29: 434-445. DOI: 10.1002/hup</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENT</head><p>This study was funded by GlaxoSmithKline and grant number DP1093834 from the Australian Research Council.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Effects of caffeine and glucose, alone and combined, on cognitive performance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><surname>Adan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josep</forename><forename type="middle">Maria</forename><surname>Serra-Grabulosa</surname></persName>
		</author>
		<idno type="DOI">10.1002/hup.1115</idno>
		<idno type="PMID">20521321</idno>
		<idno type="ark">ark:/67375/WNG-5Z93140M-M</idno>
		<idno type="istexId">A4D32D34DAFF870BCE38556F03D17361CB2FB5E0</idno>
	</analytic>
	<monogr>
		<title level="j">Human Psychopharmacology: Clinical and Experimental</title>
		<title level="j" type="abbrev">Hum. Psychopharmacol. Clin. Exp.</title>
		<idno type="ISSN">0885-6222</idno>
		<idno type="ISSNe">1099-1077</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="310" to="317" />
			<date type="published" when="2010-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Blood glucose influences memory and attention in young adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Benton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">S</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pearl</forename><forename type="middle">Y</forename><surname>Parker</surname></persName>
		</author>
		<idno type="DOI">10.1016/0028-3932(94)90147-3</idno>
		<idno type="PMID">8084417</idno>
		<idno type="PII">0028-3932(94)90147-3</idno>
		<idno type="ark">ark:/67375/6H6-WJ527GBL-8</idno>
		<idno type="istexId">5E50E0BF0D1F9C48701E7E0A8481C7AD142B6CE6</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropsychologia</title>
		<title level="j" type="abbrev">Neuropsychologia</title>
		<idno type="ISSN">0028-3932</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="595" to="607" />
			<date type="published" when="1994-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The use of analogue scales in rating subjective feelings</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alyson</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Malcolm</forename><surname>Lader</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2044-8341.1974.tb02285.x</idno>
		<idno type="ark">ark:/67375/WNG-0VD7ZD61-3</idno>
		<idno type="istexId">967253B165F0E98C5C10A82650BA8FA423F7FE8D</idno>
	</analytic>
	<monogr>
		<title level="j">British Journal of Medical Psychology</title>
		<idno type="ISSN">0007-1129</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="218" />
			<date type="published" when="1974-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Declining Blood Glucose Levels after a Cognitively Demanding Task Predict Subsequent Memory</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rachael</forename><forename type="middle">T</forename><surname>Donohoe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Benton</surname></persName>
		</author>
		<idno type="DOI">10.1080/1028415x.1999.11747295</idno>
		<idno type="PMID">27416053</idno>
	</analytic>
	<monogr>
		<title level="j">Nutritional Neuroscience</title>
		<title level="j" type="abbrev">Nutritional Neuroscience</title>
		<idno type="ISSN">1028-415X</idno>
		<idno type="ISSNe">1476-8305</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="413" to="424" />
			<date type="published" when="1999-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franz</forename><surname>Faul</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edgar</forename><surname>Erdfelder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albert-Georg</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Axel</forename><surname>Buchner</surname></persName>
		</author>
		<idno type="DOI">10.3758/bf03193146</idno>
		<idno type="PMID">17695343</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.3758%2FBF03193146.pdf" />
	</analytic>
	<monogr>
		<title level="j">Behavior Research Methods</title>
		<title level="j" type="abbrev">Behavior Research Methods</title>
		<idno type="ISSN">1554-351X</idno>
		<idno type="ISSNe">1554-3528</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="175" to="191" />
			<date type="published" when="2007-05" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Glucose and memory: fractionation of enhancement effects?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Lidder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">I</forename><surname>Sünram</surname></persName>
		</author>
		<idno type="DOI">10.1007/s002130050619</idno>
		<idno type="PMID">9683004</idno>
		<idno type="ark">ark:/67375/VQC-QRQCRWWS-L</idno>
		<idno type="istexId">19D9265595260FA2B29D902D5FBDF469E07ADB74</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="259" to="270" />
			<date type="published" when="1998-06-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Caffeine—Not just a stimulant</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Glade</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nut.2010.08.004</idno>
		<idno type="PMID">20888549</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrition</title>
		<title level="j" type="abbrev">Nutrition</title>
		<idno type="ISSN">0899-9007</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="932" to="938" />
			<date type="published" when="2010-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Development of NASA-TLX (Task Load Index): Results of Empirical and Theoretical Research</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">G</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lowell</forename><forename type="middle">E</forename><surname>Staveland</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0166-4115(08)62386-9</idno>
	</analytic>
	<monogr>
		<title level="m">Advances in Psychology</title>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="1988" />
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="139" to="183" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Crystal</forename><forename type="middle">F</forename><surname>Haskell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keith</forename><forename type="middle">A</forename><surname>Wesnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-004-2104-3</idno>
		<idno type="PMID">15678363</idno>
		<idno type="ark">ark:/67375/VQC-0WR8TXJN-6</idno>
		<idno type="istexId">38881316F4B9E7293CDB3B0B46CEC0AB49683BFA</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="813" to="825" />
			<date type="published" when="2005-01-28" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">A glucose-caffeine ‘energy drink’ ameliorates subjective and performance deficits during prolonged cognitive demand</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.appet.2004.03.001</idno>
		<idno type="PMID">15183925</idno>
	</analytic>
	<monogr>
		<title level="j">Appetite</title>
		<title level="j" type="abbrev">Appetite</title>
		<idno type="ISSN">0195-6663</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="331" to="333" />
			<date type="published" when="2004-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Attenuation of Laboratory-Induced Stress in Humans After Acute Administration of Melissa officinalis (Lemon Balm)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.psy.0000132877.72833.71</idno>
		<idno type="PMID">15272110</idno>
		<ptr type="open-access" target="http://nrl.northumbria.ac.uk/3020/1/Attenuation%20of%20Laboratory-Induced%20Stress%20in%20Humans%20After%20Acute%20Administration%20of%20Melissa%20officinalis%20%28Lemon%20Balm%29.pdf" />
	</analytic>
	<monogr>
		<title level="j">Psychosomatic Medicine</title>
		<title level="j" type="abbrev">Psychosomatic Medicine</title>
		<idno type="ISSN">0033-3174</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="607" to="613" />
			<date type="published" when="2004-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Anxiolytic effects of a combination ofMelissa ofcinalis andValeriana ofcinalis during laboratory induced stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Crystal</forename><forename type="middle">F</forename><surname>Haskell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<idno type="DOI">10.1002/ptr.1787</idno>
		<idno type="PMID">16444660</idno>
		<idno type="ark">ark:/67375/WNG-D6KFQNZD-B</idno>
		<idno type="istexId">5D8660C57815E27204DCF13C6A1274E70E7B1738</idno>
	</analytic>
	<monogr>
		<title level="j">Phytotherapy Research</title>
		<title level="j" type="abbrev">Phytother. Res.</title>
		<idno type="ISSN">0951-418X</idno>
		<idno type="ISSNe">1099-1573</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="96" to="102" />
			<date type="published" when="2006" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">PEN-SIZED DIGITAL 30-SECOND BLOOD GLUCOSE METER</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Holman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Steemson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Scott</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(87)92802-9</idno>
		<idno type="PMID">2882186</idno>
		<idno type="PII">S0140-6736(87)92802-9</idno>
		<idno type="ark">ark:/67375/6H6-TBKPF0LJ-N</idno>
		<idno type="istexId">787D1A27BD5077F6DD2E9E952CD8D8FFA8452179</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="issue">8536</biblScope>
			<biblScope unit="page" from="778" to="779" />
			<date type="published" when="1987-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The effect of glucose dose and fasting interval on cognitive function: a double-blind, placebo-controlled, six-way crossover study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lauren</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yvonne</forename><surname>Finnegan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henglong</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">I</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-011-2510-2</idno>
		<idno type="PMID">21979440</idno>
		<idno type="ark">ark:/67375/VQC-WXK0TLD0-W</idno>
		<idno type="istexId">343118D058A664CD31E82EDE1E3DB64A91386534</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="577" to="589" />
			<date type="published" when="2011-10-07" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Response variability to glucose facilitation of cognitive enhancement</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lauren</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yvonne</forename><surname>Finnegan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">I</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<idno type="DOI">10.1017/s0007114513001141</idno>
		<idno type="PMID">23789911</idno>
		<ptr type="open-access" target="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/C4137ED968E67916F31F2266D8B037DF/S0007114513001141a.pdf/div-class-title-response-variability-to-glucose-facilitation-of-cognitive-enhancement-div.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Nutrition</title>
		<title level="j" type="abbrev">Br J Nutr</title>
		<idno type="ISSN">0007-1145</idno>
		<idno type="ISSNe">1475-2662</idno>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1873" to="1884" />
			<date type="published" when="2013-06-21" />
			<publisher>Cambridge University Press (CUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The Impact of Age and Task Domain on Cognitive Performance: A Meta-Analytic Review of the Glucose Facilitation Effect</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leigh</forename><forename type="middle">M</forename><surname>Riby</surname></persName>
		</author>
		<idno type="DOI">10.1375/brim.5.2.145.58253</idno>
		<idno type="PII">S1443964600000681</idno>
		<idno type="ark">ark:/67375/6GQ-RB970Z74-K</idno>
		<idno type="istexId">F553B577A1DC7F3C760DAF710BD52060C56D6ECE</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Impairment</title>
		<title level="j" type="abbrev">Brain Impairment</title>
		<idno type="ISSN">1443-9646</idno>
		<idno type="ISSNe">1839-5252</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">02</biblScope>
			<biblScope unit="page" from="145" to="165" />
			<date type="published" when="2004-12" />
			<publisher>Cambridge University Press (CUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">V</forename><surname>Heatherley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">C</forename><surname>Hayward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><forename type="middle">E</forename><surname>Seers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marian</forename><surname>Kane</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-004-2097-y</idno>
		<idno type="PMID">15887055</idno>
		<idno type="ark">ark:/67375/VQC-1DDMV672-X</idno>
		<idno type="istexId">5944768DB98ACA679F7747455B0DAD4EB7174D7B</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="742" to="752" />
			<date type="published" when="2005-01-26" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Caffeine, mood and cognition</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1533/9780857092922.2.251</idno>
	</analytic>
	<monogr>
		<title level="m">Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness</title>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2011" />
			<biblScope unit="page" from="251" to="271" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Retrograde Enhancement of Kinesthetic Memory by Alcohol and by Glucose</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Fowles</surname></persName>
		</author>
		<idno type="DOI">10.1006/nlme.2002.4065</idno>
		<idno type="PMID">12431432</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of Learning and Memory</title>
		<title level="j" type="abbrev">Neurobiology of Learning and Memory</title>
		<idno type="ISSN">1074-7427</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="477" to="483" />
			<date type="published" when="2002-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Cognitive and physiological effects of an ?energy drink?: an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-004-1935-2</idno>
		<idno type="PMID">15549275</idno>
		<idno type="ark">ark:/67375/VQC-S8F85L3W-9</idno>
		<idno type="istexId">A3C5229A0F233CEC5444D00576AF87864ACC28B9</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="320" to="330" />
			<date type="published" when="2004-07-31" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cognitive demand and blood glucose</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><surname>Harper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0031-9384(01)00476-0</idno>
		<idno type="PMID">11495663</idno>
		<idno type="PII">S0031-9384(01)00476-0</idno>
		<idno type="ark">ark:/67375/6H6-XV9G9032-G</idno>
		<idno type="istexId">3339A6DBD20DAADA67DE0B741F82556623E299F4</idno>
	</analytic>
	<monogr>
		<title level="j">Physiology &amp; Behavior</title>
		<title level="j" type="abbrev">Physiology &amp; Behavior</title>
		<idno type="ISSN">0031-9384</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="585" to="592" />
			<date type="published" when="2001-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Blood glucose changes and memory: Effects of manipulating emotionality and mental effort</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsycho.2005.02.003</idno>
		<idno type="PMID">15885875</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychology</title>
		<title level="j" type="abbrev">Biological Psychology</title>
		<idno type="ISSN">0301-0511</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="19" />
			<date type="published" when="2006-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Chewing gum alleviates negative mood and reduces cortisol during acute laboratory psychological stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Crystal</forename><surname>Haskell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernadette</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthea</forename><surname>Milne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Wetherell</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.physbeh.2009.02.028</idno>
		<idno type="PMID">19268676</idno>
		<ptr type="open-access" target="http://nrl.northumbria.ac.uk/6/1/Scholey%20Wetherell%202009%20chewing%20gum%20%20stress%20accepted.pdf" />
	</analytic>
	<monogr>
		<title level="j">Physiology &amp; Behavior</title>
		<title level="j" type="abbrev">Physiology &amp; Behavior</title>
		<idno type="ISSN">0031-9384</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="304" to="312" />
			<date type="published" when="2009-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Glucose administration prior to a divided attention task improves tracking performance but not word recognition: evidence against differential memory enhancement?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">B</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">I</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><surname>Greer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jade</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">O</forename><surname>Kennedy</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-008-1387-1</idno>
		<idno type="PMID">18979086</idno>
		<idno type="ark">ark:/67375/VQC-370WM4ZT-Z</idno>
		<idno type="istexId">0B83991EE1A3954A6C10B24F1319CDA01F9AF2CD</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="549" to="558" />
			<date type="published" when="2008-11-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Glucose enhancement of recognition memory: Differential effects on effortful processing but not aspects of ‘remember-know’ responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><surname>Scholey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><surname>Macpherson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jade</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Con</forename><surname>Stough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Kennedy</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropharm.2012.06.030</idno>
		<idno type="PMID">22766389</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<title level="j" type="abbrev">Neuropharmacology</title>
		<idno type="ISSN">0028-3908</idno>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="544" to="549" />
			<date type="published" when="2013-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Glucose and caffeine effects on sustained attention: an exploratory fMRI study.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josep</forename><forename type="middle">M</forename><surname>Serra-Grabulosa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><surname>Adan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carles</forename><surname>Falcón</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Núria</forename><surname>Bargalló</surname></persName>
		</author>
		<idno type="DOI">10.1002/hup.1150</idno>
		<idno type="PMID">21312288</idno>
		<idno type="ark">ark:/67375/WNG-KMH26GX4-J</idno>
		<idno type="istexId">2D9AB19519F425ED80D624D88AB150B4619D3E92</idno>
	</analytic>
	<monogr>
		<title level="j">Human Psychopharmacology: Clinical and Experimental</title>
		<title level="j" type="abbrev">Hum. Psychopharmacol. Clin. Exp.</title>
		<idno type="ISSN">0885-6222</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="n/a" to="n/a" />
			<date type="published" when="2010" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
		<idno type="DOI">10.1007/s002130000506</idno>
		<idno type="PMID">11057520</idno>
		<idno type="ark">ark:/67375/VQC-FS9Z4W9V-H</idno>
		<idno type="istexId">D9ABA7AAF0F39450C0CCA0154BBB6DBC2EEE3587</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="167" to="173" />
			<date type="published" when="2000-10-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mood and Cognitive Performance Effects of &quot;Energy&quot; Drink Constituents: Caffeine, Glucose and Carbonation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Cotton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
		<idno type="DOI">10.1080/10284150400003041</idno>
		<idno type="PMID">15526987</idno>
	</analytic>
	<monogr>
		<title level="j">Nutritional Neuroscience</title>
		<title level="j" type="abbrev">Nutritional Neuroscience</title>
		<idno type="ISSN">1028-415X</idno>
		<idno type="ISSNe">1476-8305</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="127" to="139" />
			<date type="published" when="2004-06" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Effects of caffeine on human behavior</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0278-6915(02)00096-0</idno>
		<idno type="PMID">12204388</idno>
	</analytic>
	<monogr>
		<title level="j">Food and Chemical Toxicology</title>
		<title level="j" type="abbrev">Food and Chemical Toxicology</title>
		<idno type="ISSN">0278-6915</idno>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1243" to="1255" />
			<date type="published" when="2002-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Glucose enhancement of human memory: A comprehensive research review of the glucose memory facilitation effect</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leigh</forename><forename type="middle">M</forename><surname>Riby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jam</forename><forename type="middle">Anke M Van</forename><surname>Eekelen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">K</forename><surname>Foster</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neubiorev.2010.09.008</idno>
		<idno type="PMID">20883717</idno>
		<ptr type="open-access" target="http://nrl.northumbria.ac.uk/4103/1/Smith_et_al._%282011%29_NBR.pdf" />
	</analytic>
	<monogr>
		<title level="j">Neuroscience &amp; Biobehavioral Reviews</title>
		<title level="j" type="abbrev">Neuroscience &amp; Biobehavioral Reviews</title>
		<idno type="ISSN">0149-7634</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="770" to="783" />
			<date type="published" when="2011-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">State-Trait Anxiety Inventory for Children</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">D</forename><surname>Spielberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">D</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Montouri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Lushene</surname></persName>
		</author>
		<idno type="DOI">10.1037/t06497-000</idno>
	</analytic>
	<monogr>
		<title level="m">Manual for the State-Trait Anxiety Inventory</title>
		<imprint>
			<publisher>American Psychological Association (APA)</publisher>
			<date type="published" when="1973" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Investigation into the significance of task difficulty and divided allocation of resources on the glucose memory facilitation effect</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">I</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">K</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paula</forename><surname>Durlach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catalina</forename><surname>Perez</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00213-001-0987-9</idno>
		<idno type="PMID">11919666</idno>
		<idno type="ark">ark:/67375/VQC-N2B935FD-G</idno>
		<idno type="istexId">7C4E7D3C3FA6E81CE3BDB0BC4BBBB674CFFB6852</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<title level="j" type="abbrev">Psychopharmacology</title>
		<idno type="ISSN">0033-3158</idno>
		<idno type="ISSNe">1432-2072</idno>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="387" to="397" />
			<date type="published" when="2002-02-08" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The effect of glucose administration on the recollection and familiarity components of recognition memory</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">I</forename><surname>Sünram-Lea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">A</forename><surname>Dewhurst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">K</forename><surname>Foster</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsycho.2007.09.006</idno>
		<idno type="PMID">17950982</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Psychology</title>
		<title level="j" type="abbrev">Biological Psychology</title>
		<idno type="ISSN">0301-0511</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="75" />
			<date type="published" when="2008-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The Multitasking Framework: The Effects of Increasing Workload on Acute Psychobiological Stress Reactivity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Wetherell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kirsty</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1002/smi.2496</idno>
		<idno type="PMID">23723144</idno>
		<idno type="ark">ark:/67375/WNG-SNLTMXTJ-B</idno>
		<idno type="istexId">E1789A5F28CFFC7A6C77F6104EE0D0FCFD164A68</idno>
		<ptr type="open-access" target="http://nrl.northumbria.ac.uk/13167/1/Wetherell_%26_Carter_Multitasking_Framework_Proofs.pdf" />
	</analytic>
	<monogr>
		<title level="j">Stress and Health</title>
		<title level="j" type="abbrev">Stress Health</title>
		<idno type="ISSN">1532-3005</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="103" to="109" />
			<date type="published" when="2013-05-30" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Secretory immunoglobulin-A reactivity following increases in workload intensity using the Defined Intensity Stressor Simulation (DISS)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Wetherell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><forename type="middle">C</forename><surname>Sidgreaves</surname></persName>
		</author>
		<idno type="DOI">10.1002/smi.1038</idno>
		<idno type="ark">ark:/67375/WNG-RSCQ7XJQ-3</idno>
		<idno type="istexId">74B7402B9C905A1722B097354AD4CE315ECE7919</idno>
	</analytic>
	<monogr>
		<title level="j">Stress and Health</title>
		<title level="j" type="abbrev">Stress and Health</title>
		<idno type="ISSN">1532-3005</idno>
		<idno type="ISSNe">1532-2998</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="99" to="106" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
